Abstract
We compared patient morbidity associated with temporomandibular joint (TMJ) arthrography using both meglumine/sodium diatrizoate (60%) and the new monoacidic dimer, Hexabrix, in a double-blind randomized clinical trial in 31 patients. Patients experienced maximal discomfort from TMJ arthrography with the initial joint filling and joint distension; this rapidly resolved over 10 minutes. Delayed exacerbation of pain is less than described for shoulder arthrography. The newer contrast media promise to decrease patient morbidity with arthrography.
Original language | English (US) |
---|---|
Pages (from-to) | 245-246 |
Number of pages | 2 |
Journal | Radiology |
Volume | 155 |
Issue number | 1 |
State | Published - 1985 |
Externally published | Yes |
ASJC Scopus subject areas
- Radiological and Ultrasound Technology